These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32962774)

  • 1. Inpatient fluoroquinolone use in Veterans' Affairs hospitals is a predictor of
    Silva SY; Wilson BM; Redmond SN; Donskey CJ
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):57-62. PubMed ID: 32962774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Reduced Fluoroquinolone Use on
    Redmond SN; Silva SY; Wilson BM; Cadnum JL; Donskey CJ
    Pathog Immun; 2019; 4(2):251-259. PubMed ID: 31637329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare facility-onset, healthcare facility-associated
    Evans CT; Fitzpatrick M; Ramanathan S; Kralovic SM; Burns SP; Goldstein B; Smith B; Gerding DN; Johnson S
    J Spinal Cord Med; 2020 Sep; 43(5):642-652. PubMed ID: 31663843
    [No Abstract]   [Full Text] [Related]  

  • 4. Increasing prevalence of the epidemic ribotype 106 in healthcare facility-associated and community-associated Clostridioides difficile infection.
    Suárez-Bode L; Barrón R; Pérez JL; Mena A
    Anaerobe; 2019 Feb; 55():124-129. PubMed ID: 30550807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset
    Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal trends of inpatient
    Sumon ZE; Lesse AJ; Sellick JA; Tetewsky S; Mergenhagen KA
    Infect Control Hosp Epidemiol; 2020 Jan; 41(1):44-51. PubMed ID: 31708000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile infections in Veterans Health Administration acute care facilities.
    Evans ME; Simbartl LA; Kralovic SM; Jain R; Roselle GA
    Infect Control Hosp Epidemiol; 2014 Aug; 35(8):1037-42. PubMed ID: 25026621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics and healthcare facility-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update.
    Slimings C; Riley TV
    J Antimicrob Chemother; 2021 Jun; 76(7):1676-1688. PubMed ID: 33787887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A targeted assessment for prevention strategy to decrease
    Roselle GA; Evans ME; Simbartl LA; McCauley BP; Lipscomb KR; Clifton M
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):302-305. PubMed ID: 31896374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing Fluoroquinolone Use and Clostridioides difficile Infections in Community Nursing Homes Through Hospital-Nursing Home Collaboration.
    Felsen CB; Dodds Ashley ES; Barney GR; Nelson DL; Nicholas JA; Yang H; Aydelotte ME; Karlic A; Nicholas NC; Petrone KK; Pine RD; Schabel SL; Medina-Walpole A; Dumyati GK
    J Am Med Dir Assoc; 2020 Jan; 21(1):55-61.e2. PubMed ID: 31888865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shift to community-onset Clostridium difficile infection in the national Veterans Health Administration, 2003-2014.
    Reveles KR; Pugh MJV; Lawson KA; Mortensen EM; Koeller JM; Argamany JR; Frei CR
    Am J Infect Control; 2018 Apr; 46(4):431-435. PubMed ID: 29126751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone-associated adverse events of interest among hospitalized veterans affairs patients with community-acquired pneumonia who were treated with a fluoroquinolone: A focus on tendonitis, Clostridioides difficile infection, and aortic aneurysm.
    Patel N; Gorseth A; Belfiore G; Stornelli N; Lowry C; Thomas L
    Pharmacotherapy; 2024 Jan; 44(1):49-60. PubMed ID: 37699580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
    Putsathit P; Hong S; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
    J Antimicrob Chemother; 2021 Jun; 76(7):1815-1821. PubMed ID: 33895826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in time-to-testing and time-to-isolation between community-onset and hospital-onset Clostridioides difficile cases at a tertiary care VA medical center.
    Hostler CJ; Bertumen JB; Park LP; Wilkins SB; Woods CW
    Am J Infect Control; 2020 Oct; 48(10):1148-1151. PubMed ID: 31911067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial stewardship program achieved marked decrease in Clostridium difficile infections in a Veterans Hospital.
    Morgan F; Belal M; Lisa B; Ford F; LeMaitre B; Psevdos G
    Am J Infect Control; 2020 Sep; 48(9):1119-1121. PubMed ID: 32035688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Observational Cohort Study of
    Rao K; Higgins PDR; Young VB
    mSphere; 2018; 3(3):. PubMed ID: 29794054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of prevention practices with rates of health care-associated
    Musuuza JS; McKinley L; Keating JA; Obasi C; Knobloch MJ; Crnich C; Evans CT; Evans ME; Livorsi D; Morgan DJ; Perencevich EN; Reisinger HS; Schweizer ML; Suda KJ; Simbartl LA; Safdar N
    Infect Control Hosp Epidemiol; 2020 Jan; 41(1):52-58. PubMed ID: 31658933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing incidence of Clostridium difficile ribotype 001 associated with severe course of the infection and previous fluoroquinolone use in the Czech Republic, 2015.
    Krutova M; Matejkova J; Drevinek P; Kuijper EJ; Nyc O;
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2251-2258. PubMed ID: 28681203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reductions in inpatient fluoroquinolone use and postdischarge
    Jones KA; Onwubiko UN; Kubes J; Albrecht B; Paciullo K; Howard-Anderson J; Suchindran S; Trible R; Jacob JT; Yi SH; Goodenough D; Fridkin SK; Sexton ME; Wiley Z
    Antimicrob Steward Healthc Epidemiol; 2021; 1(1):e32. PubMed ID: 36168449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.
    Ramanathan S; Johnson S; Burns SP; Kralovic SM; Goldstein B; Smith B; Gerding DN; Evans CT
    Am J Infect Control; 2014 Feb; 42(2):168-73. PubMed ID: 24485372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.